![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Bladder Cancer |
Free Subscription
1 Acta Med Port |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Bladder Cancer is free of charge.
Immunotherapy in the Treatment of Metastatic Urothelial Carcinoma at a Tertiary
Referral Center in Portugal.
Acta Med Port. 2023;36:145-146.
PubMed
Patterns of treatment in older patients with newly diagnosed advanced bladder
cancer: A SEER dataset analysis.
Aging Cancer. 2022;3:105-115.
PubMed
Abstract available
Proteomic strategies for urothelial bladder cancer diagnosis, prognosis and
treatment: Trends for tumor biomarker sources.
Anal Biochem. 2023 Feb 2:115074. doi: 10.1016/j.ab.2023.115074.
PubMed
Abstract available
Combination toripalimab and bevacizumab for an elderly urothelial carcinoma
patient with brain metastasis who failed rapidly after radiotherapy: a case
report and literature review.
Anticancer Drugs. 2023;34:317-324.
PubMed
Abstract available
Revisit the rare clinical cases of upper urinary tract metastases from
gastrointestinal tumors.
Asian J Surg. 2023;46:1103-1104.
PubMed
Primary bladder amyloidosis mimicking bladder malignancy: A case report.
Asian J Surg. 2023;46:1033-1035.
PubMed
Multifocal Xanthogranulomatous cystitis mimicking bladder malignancy: A case
report and literature review.
Asian J Surg. 2023;46:969-970.
PubMed
Clinical outcomes of adapted hypofractionated radiotherapy for bladder cancer in
elderly patients.
BJU Int. 2023 Feb 6. doi: 10.1111/bju.15983.
PubMed
Abstract available
Prognostic impact of variant histologies in urothelial bladder cancer treated by
radical cystectomy.
BJU Int. 2023 Feb 6. doi: 10.1111/bju.15984.
PubMed
Abstract available
The tumour-associated stroma correlates with poor clinical outcomes and
immunoevasive contexture in patients with upper tract urothelial carcinoma:
results from a multicenter real-world study (TSU-01 Study).
Br J Cancer. 2023;128:310-320.
PubMed
Abstract available
mu-opioid receptor agonist facilitates circulating tumor cell formation in bladder
cancer via the MOR/AKT/Slug pathway: a comprehensive study including randomized
controlled trial.
Cancer Commun (Lond). 2023 Feb 5. doi: 10.1002/cac2.12408.
PubMed
Abstract available
Identification and validation of molecular subtype and prognostic signature for
bladder cancer based on neutrophil extracellular traps.
Cancer Invest. 2023 Feb 10:1-12. doi: 10.1080/07357907.2023.2179063.
PubMed
Abstract available
Salvage Percutaneous Cryoablation for Bleeding Upper Tract Urothelial Carcinoma.
Cardiovasc Intervent Radiol. 2023;46:255-258.
PubMed
Abstract available
Ligustilide Induces Apoptosis and Reduces Proliferation in Human Bladder Cancer
Cells by NFkappaB1 and Mitochondria Pathway.
Chem Biol Drug Des. 2023 Feb 8. doi: 10.1111/cbdd.14207.
PubMed
Abstract available
Preoperative Cell-Free DNA (cfDNA) in Muscle-Invasive Bladder Cancer Treatment
Outcome.
Clin Chem. 2023 Feb 4:hvac218. doi: 10.1093.
PubMed
Abstract available
The inclusion of nuclear area improves the Paris system for reporting urinary
cytology.
Cytopathology. 2023;34:106-112.
PubMed
Abstract available
Immunohistochemical based molecular subtypes of muscle-invasive bladder cancer:
association with HER2 and EGFR alterations, neoadjuvant chemotherapy response and
survival.
Diagn Pathol. 2023;18:11.
PubMed
Abstract available
Re: IL-15 Superagonist NAI in BCG-Unresponsive Non-muscle-invasive Bladder
Cancer.
Eur Urol. 2023 Feb 1:S0302-2838(23)00016-7. doi: 10.1016/j.eururo.2023.
PubMed
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with
Chemoradiotherapy Versus Chemoradiotherapy Alone in Muscle-invasive Bladder
Cancer: The MK-3475-992/KEYNOTE-992 Trial.
Eur Urol Focus. 2023 Feb 1:S2405-4569(22)00295-4. doi: 10.1016/j.euf.2022.
PubMed
Abstract available
Mapping the tumor microenvironment in bladder cancer and exploring the prognostic
genes by single-cell RNA sequencing.
Front Oncol. 2023;12:1105026.
PubMed
Abstract available
[A Case of Laparoscopic Surgery for Sigmoid Colon Cancer after Cystectomy and
Ileal Conduit Construction].
Gan To Kagaku Ryoho. 2022;49:1870-1872.
PubMed
Abstract available
[Case of Robot-Assisted Low Anterior Resection with Total Cystectomy for Rectal
Cancer Invading the Urinary Bladder/Prostate in Collaboration with Urologists].
Gan To Kagaku Ryoho. 2022;49:1565-1567.
PubMed
Abstract available
[A Case of Robotic-Assisted Surgery for Simultaneous Triple Cancer of Rectum,
Bladder, and Prostate].
Gan To Kagaku Ryoho. 2022;49:1676-1677.
PubMed
Abstract available
Evaluation of thermal dose effect in radiofrequency-induced hyperthermia with
intravesical chemotherapy for nonmuscle invasive bladder cancer.
Int J Hyperthermia. 2023;40:2157498.
PubMed
Abstract available
A comparative study of attention mechanism based deep learning methods for
bladder tumor segmentation.
Int J Med Inform. 2023;171:104984.
PubMed
Abstract available
Urothelial carcinoma in a Russian tortoise (Testudohorsfieldii).
J Comp Pathol. 2023;200:18-22.
PubMed
Abstract available
Development of a New Two-Arm Transurethral Surgical System for En Bloc Resection
of Bladder Tumor: A Preclinical Study.
J Endourol. 2023;37:165-170.
PubMed
Abstract available
Is Robotic Superior to Laparoscopic Approach for Radical Nephroureterectomy with
Bladder Cuff Excision in Treating Upper Urinary Tract Urothelial Carcinoma?
J Endourol. 2023;37:139-146.
PubMed
Abstract available
J Environ Pathol Toxicol Oncol
Receptor Tyrosine Kinase Pathway and Infiltrating Urothelial Carcinoma.
J Environ Pathol Toxicol Oncol. 2023;42:65-77.
PubMed
Abstract available
HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via
inhibiting glycolysis through IGF2BP1/PKM2 pathway.
J Exp Clin Cancer Res. 2023;42:41.
PubMed
Abstract available
Effect of Antacid Use on Immune Checkpoint Inhibitors in Advanced Solid Cancer
Patients: A Systematic Review and Meta-analysis.
J Immunother. 2023;46:43-55.
PubMed
Abstract available
Clinical significance of galectin-3 expression in urinary bladder carcinoma.
J Int Med Res. 2023;51:3000605231153323.
PubMed
Abstract available
Re: Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to
Radical Cystectomyis Prognostic but Not Therapeutic.
J Urol. 2023 Feb 8:101097JU0000000000003362. doi: 10.1097/JU.0000000000003362.
PubMed
Letter to the Editor: clinical utility of urine DNA for noninvasive detection and
minimal residual disease monitoring in urothelial carcinoma.
Mol Cancer. 2023;22:25.
PubMed
Abstract available
Bladder tuberculosis with ureteral strictures after bacillus Calmette‑Guerin
therapy for urinary bladder cancer: A case report.
Mol Clin Oncol. 2022;18:7.
PubMed
Abstract available
A novel bidirectional perfusion-like administered system for NIR-II fluorescence
imaging precision diagnosis of bladder cancer.
Nanomedicine. 2023;49:102661.
PubMed
Abstract available
Elicitation of Health State Utilities Associated with Progression from Bacillus
Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC).
Pharmacoecon Open. 2023 Feb 3. doi: 10.1007/s41669-023-00392.
PubMed
Abstract available
Preoperative upper tract invasive diagnostic modalities are associated with
intravesical recurrence following surgery for upper tract urothelial carcinoma: A
population-based study.
PLoS One. 2023;18:e0281304.
PubMed
Abstract available
The ratio of adaptive to innate immune cells differs between genders and
associates with improved prognosis and response to immunotherapy.
PLoS One. 2023;18:e0281375.
PubMed
Abstract available
Impact of an optimized surveillance protocol based on the European Association of
Urology substratification on surveillance costs in patients with primary
high-risk non-muscle-invasive bladder cancer.
PLoS One. 2023;18:e0275921.
PubMed
Abstract available
PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder
urothelial carcinoma.
Sci Rep. 2023;13:2051.
PubMed
Abstract available
Nonbilharzial Squamous Cell Bladder Cancer: An Indian Experience.
South Asian J Cancer. 2022;11:322-325.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by